Handok Inc. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
15,523
3,655
717
9,775
6,696
9,344
Depreciation, Depletion & Amortization
11,067
13,075
14,171
14,789
17,655
19,911
Other Funds
-
54
56
702
477
13,564
Funds from Operations
16,547
28,614
25,247
24,724
20,620
42,818
Changes in Working Capital
7,268
9,025
10,607
33,226
13,829
13,363
Net Operating Cash Flow
9,279
37,638
14,640
8,502
6,791
29,456
Capital Expenditures
13,778
14,333
17,056
31,686
40,699
Sale of Fixed Assets & Businesses
1,049
770
442
1,102
13,998
Purchase/Sale of Investments
8,020
5,929
237
16,299
24,500
Net Investing Cash Flow
20,697
78,460
22,226
63,783
2,540
Cash Dividends Paid - Total
1,740
2,320
1,867
1,245
1,556
Issuance/Reduction of Debt, Net
14,125
33,653
4,000
73,644
20,778
Net Financing Cash Flow
12,385
44,927
12,174
73,101
18,745
Net Change in Cash
967
4,105
4,594
818
22,909
Free Cash Flow
2,601
25,919
2,047
39,538
22,307
Net Assets from Acquisitions
-
57,778
5,880
19,514
-
Other Sources
1,294
595
868
3,016
410
Change in Capital Stock
-
13,648
9,985
-
-
Exchange Rate Effect
-
-
6
2
86
Other Uses
1,242
1,786
362
403
750

About Handok

View Profile
Address
132 Teheran-ro
Seoul SL 06235
Korea, Republic Of
Employees -
Website http://www.handok.co.kr
Updated 07/08/2019
Handok, Inc. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Medicine, Medical Device, Healthcare Product, Rental, and Gene Analysis. The Medicine business offers ETC and OTC medicines.